| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $600K | — |
| R&D Expense | $41.5M | -22.5% |
| SG&A Expense | $19.6M | -22.7% |
| Operating Income | -$60.5M | +23.4% |
| Pre-tax Income | -$55.5M | +23.4% |
| Income Tax | $0 | — |
| Net Income | -$57.8M | +22.5% |
| EPS (Basic) | -$1.33 | +27.7% |
| EPS (Diluted) | -$1.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.9M | -43.2% |
| Short-term Investments | $51.6M | -39.6% |
| Current Assets | $67.8M | -40.9% |
| Total Assets | $68.1M | -41.1% |
| Current Liabilities | $6.2M | -32.6% |
| Total Liabilities | $6.5M | -31.6% |
| Stockholders' Equity | $61.7M | -41.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.3M | +18.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $33.5M | +21.1% |
| Financing Cash Flow | $5.2M | +3535.7% |
| Free Cash Flow | -$49.3M | +18.2% |
| +27.7% |